Recent Advances in Sepsis
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Laboratory Medicine".
Deadline for manuscript submissions: 31 December 2025
Special Issue Editor
2. University Clinical Hospital Center "Bezanijska Kosa", Belgrade, Serbia
Interests: antibiotics; ischemia-reperfusion injury; lipidomics; pharmacovigilance; bioethics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Sepsis remains a leading cause of morbidity and mortality worldwide, posing significant challenges to healthcare systems. Despite advances in understanding its pathophysiology and management, sepsis continues to demand innovative diagnostic, therapeutic, and preventive strategies. This Special Issue, "Recent Advances in Sepsis", brings together cutting-edge research and reviews that highlight progress in sepsis care, from molecular mechanisms to clinical interventions. Topics include novel biomarkers, immune modulation, precision medicine approaches, and emerging therapies that aim to improve patient outcomes. Additionally, we explore advancements in sepsis surveillance, antimicrobial stewardship, and supportive care. By compiling multidisciplinary perspectives, this issue aims to foster collaboration among researchers and clinicians, ultimately contributing to the global fight against sepsis. We invite readers to explore these findings and join the ongoing effort to redefine sepsis management in the modern era.
Prof. Dr. Zoran Todorovic
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- sepsis
- biomarkers
- diagnosis
- personalized medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
